| Legal Entity | Jurisdiction | Relationship with the IM Cannabis Corp. |
I.M.C Holdings Ltd. (“IMC Holdings”) | Israel | Wholly-owned subsidiary |
Focus Medical Herbs Ltd. (“Focus”) | Israel | Private company over which IMC Holdings exercises “de facto control” under IFRS 10 |
IM Cannabis Holding NL B.V Netherlands (“IMC Holdings NL”) | Netherlands | Wholly-owned subsidiary of IMC Holdings |
I.M.C. Pharma Israel Ltd. (“IMC Pharma”) | Israel | Wholly-owned subsidiary of IMC Holdings |
I.M.C Farms Israel Ltd. (“IMC Farms”) | Israel | Wholly-owned subsidiary of IMC Holdings |
IMCC Medical Herbs Ltd. (“IMCC Medical Herbs”) | Israel | Wholly-owned subsidiary of IMC Holdings |
Xinteza API Ltd (“Xinteza”) | Israel | Subsidiary of IMC Holdings |
Shiran Societe Anonyme (“Greece”) | Greece | Subsidiary of IMC Holdings |
R.A. Yarok Pharm Ltd. (“Pharm Yarok”) | Israel | Wholly-owned subsidiary of IMC Holdings |
Rosen High Way Ltd. (“Rosen High Way”) | Israel | Wholly-owned subsidiary of IMC Holdings |
Revoly Trading and Marketing Ltd. dba Vironna Pharm (“Vironna”) | Israel | Subsidiary of IMC Holdings |
Oranim Plus Pharm Ltd. (“Oranim Plus”) | Israel | Subsidiary of IMC Holdings |
High Way Shinua Ltd. (“High Way Shinua”) | Israel | Subsidiary of IMC Holdings |
Oranim Pharm (“Oranim Pharm”) | Israel | Subsidiary of Oranim Plus |
Adjupharm GmbH (“Adjupharm”) | Germany | Subsidiary of IMC Holdings |
